Consonance Capital Management LP - KERYX BIOPHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 133 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Consonance Capital Management LP ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$37,129,000
-26.7%
5,229,455
-25.3%
4.11%
-31.2%
Q2 2017$50,646,000–7,005,041–5.97%–
 Download
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$30.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders